Description
There is provided a tolerogenic human peptide, capable of binding to an MHC class I or II molecule without further antigen processing, for use in the treatment and/or prevention of multiple sclerosis, which peptide is selected from the following myelin basic protein (MBP) peptides: 83-99 and 131- 145.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Official Data Source | HTML | Access the complete Patent AT-E401343-T1: [Translated] TOLEROGENIC PEPTIDES on the official website. | Open resource |